
-
Japan ruling party to pick new leader on October 4
-
Ethiopia inaugurates Africa's biggest dam
-
Miners Anglo American, Teck plan new copper giant
-
Suriname stun El Salvador, allege racist chants in WC qualifying
-
Macron scrambles to find new French PM as Bayrou set to resign
-
Death of Hong Kong's Lai would strengthen democracy message, son says
-
Markets mainly rise on US rate cut hopes
-
Korean women target US military in landmark forced prostitution lawsuit
-
Mistral cements AI lead in Europe with cash infusion
-
Israel says to act with 'great force' in Gaza City
-
South Korean women sue US military in landmark prostitution lawsuit
-
40 years of 'Mario' games that have grown up with fans
-
AI and iPhones likely stars of Apple event
-
Thaksin termination? Prison term latest chapter in political odyssey
-
Merz to open Munich motor show as engine row threatens to combust
-
Quiet Tebogo's legs to 'do the talking' in Lyles 200m worlds battle
-
Gaza aid flotilla says hit by drone, Tunisia says none detected
-
Thai top court orders ex-PM Thaksin jailed for one year
-
All Blacks great McCaw inspires squad ahead of Springboks rematch
-
Maduro decrees Christmas in October for Venezuela, again
-
New Zealand police detail slain fugitive father's life on the run
-
McCarthy sparks late rally as Vikings edge Bears in NFL opener
-
Suriname stuns El Salvador in 2026 World Cup qualifying
-
London arms show opens under Israel cloud
-
ICC hears charges against Ugandan warlord Kony
-
Most Asian markets rise on US rate hopes, Tokyo hits record
-
Nottingham Forest sack head coach Nuno after rift with owner
-
Thai top court to rule on ex-PM Thaksin's prison term
-
Major social media sites back online in Nepal after deadly protests
-
From rocky start to Oscar hopeful: Dwayne Johnson hits Toronto
-
Murdoch family settles dispute over media empire succession
-
Trump's alleged birthday note to Epstein released by House panel
-
Killing Hong Kong's Lai would strengthen democracy message, son says
-
D-Day approaches in Bolsonaro coup trial
-
Israel film at Toronto fest entrenches industry split over Gaza
-
Thai top court to rule on ex-PM Thaksin's prison stay
-
North Korea's Kim oversees ICBM engine test: state media
-
Nottingham Forest sack boss Nuno Espirito Santo
-
Elevating Imaging, Empowering Flow - AGFA HealthCare at RSNA 2025
-
Star Copper Commences Phase 2 Drill Campaign and Advances Copper Creek Target Activities
-
Angle PLC Announces Change of Adviser
-
Alset AI Provides Corporate Update Highlighting Foundation for Growth
-
Angle PLC Announces Interim Results
-
Trump admin launches immigration raids in Chicago
-
Murdoch family settles dispute on control of media assets
-
Norway PM's left bloc wins election, populists surge
-
Italy avoid disaster, Kosovo win in World Cup qualifying
-
Tonali saves Italy from World Cup disaster against Israel
-
Late Ben Romdhane goal seals Tunisia berth in 2026 World Cup
-
OpenAI backs AI-animated film for Cannes debut

The Global PAD Association has presented the 2025 Walking As Therapy Breakthrough Research of the Year award to The STRIDE Trial Research Team led by Dr. Marc P. Bonaca
AURORA, CO / ACCESS Newswire / September 5, 2025 / The Global PAD Association has presented the 2025 Walking As Therapy Breakthrough Research of the Year award to The STRIDE Trial Research Team led by Dr. Marc P. Bonaca, Executive Director at CPC Clinical Research, for pioneering research demonstrating significant improvements in walking capacity, symptoms, and quality of life for peripheral artery disease patients through innovative therapeutic intervention. The STRIDE trial represents a landmark advancement that transforms our understanding of walking therapy and opens new frontiers in PAD treatment. The STRIDE trial results were presented at the American College of Cardiology scientific sessions in March 2025 and simultaneously published in the Lancet.
Dr. Marc P. Bonaca can be reached by media at [email protected] or 303-860-9900.
CPC press contact: [email protected]
CPC Clinical Research & CPC Community Health
2115 N. Scranton St., Suite 2040
Aurora, CO 80045-7120
About CPC Clinical Research
CPC Clinical Research is an academic research organization affiliated with the University of Colorado that is recognized for its expertise in innovative, pragmatic clinical trial design & management for both national and international clinical research. CPC has over 30 years of experience in managing all stages and types of clinical trials.
For more information, please visit https://cpcclinicalresearch.org/
SOURCE: CPC
View the original press release on ACCESS Newswire
Th.Berger--AMWN